Chicago-based cancer-fighting data startup Tempus is now valued at $2 billion.
The company, led by Groupon co-founder Eric Lefkofsky, announced Wednesday that it raised another $110 million from new and existing investors. Tempus gathers and analyzes data for doctors to use in cancer treatment, and it plans to use the money to apply its technology to treating other diseases and to expand outside the U.S.
Hospitals and health care systems Tempus works with have been asking if the company would ever consider expanding into other disease areas, Lefkofsky said.
“For a while our heads were down, but there was a point when we felt like the...